This statistic displays the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in U.S. dollars. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014
(in U.S. dollars)
Values are for drugs delivered in the physician office and at home.
* Drugs used for treatment of patients with cancer. Pricing data reflects 4th quarter 2014 payment rates, which correspond to 2nd quarter 2014
manufacturer reports.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
American Society of Clinical Oncology. (March 17, 2016). Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars) [Graph]. In Statista. Retrieved December 31, 2024, from https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/
American Society of Clinical Oncology. "Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars)." Chart. March 17, 2016. Statista. Accessed December 31, 2024. https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/
American Society of Clinical Oncology. (2016). Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars). Statista. Statista Inc.. Accessed: December 31, 2024. https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/
American Society of Clinical Oncology. "Leading Medicare Part B Cancer Drugs Based on Average Sales Price per Dosage in 2014 (in U.S. Dollars)." Statista, Statista Inc., 17 Mar 2016, https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/
American Society of Clinical Oncology, Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars) Statista, https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/ (last visited December 31, 2024)
Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars) [Graph], American Society of Clinical Oncology, March 17, 2016. [Online]. Available: https://www.statista.com/statistics/418664/top-cancer-drugs-paid-by-medicare-part-b-by-sales-price-per-dosage/
